Clinical Study Service Contract
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 111332 Grape Vineyards
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration's Center for Devices and Radiological Health (CDRH) is procuring clinical study services to support regulatory validation of medical devices using existing public datasets, with solicitation release estimated for May 1, 2027 and award by September 1, 2027. The contract directly supports CDRH's strategic priorities by enabling medical device sponsors to leverage existing public datasets for regulatory validation, thereby reducing costly duplicative clinical studies and lowering barriers for validating devices intended for underrepresented populations.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to cdhracquisitions@fda.hhs.gov.
Forecast text
This initiative directly supports CDRH's strategic priorities by enabling medical device sponsors to leverage existing public datasets for regulatory validation, thereby reducing costly duplicative clinical studies and lowering barriers for validating devices intended for underrepresented populations.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast